Compare Novartis with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs AJANTA PHARMA - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS AJANTA PHARMA NOVARTIS/
AJANTA PHARMA
 
P/E (TTM) x 849.2 28.4 2,992.7% View Chart
P/BV x 25.5 5.9 432.0% View Chart
Dividend Yield % 1.7 0.6 290.1%  

Financials

 NOVARTIS   AJANTA PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-19
AJANTA PHARMA
Mar-19
NOVARTIS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs9801,422 68.9%   
Low Rs600898 66.9%   
Sales per share (Unadj.) Rs198.7233.5 85.1%  
Earnings per share (Unadj.) Rs21.044.0 47.7%  
Cash flow per share (Unadj.) Rs22.352.2 42.7%  
Dividends per share (Unadj.) Rs10.009.00 111.1%  
Dividend yield (eoy) %1.30.8 163.1%  
Book value per share (Unadj.) Rs307.5255.1 120.5%  
Shares outstanding (eoy) m24.6988.02 28.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.05.0 80.0%   
Avg P/E ratio x37.726.4 142.8%  
P/CF ratio (eoy) x35.522.2 159.6%  
Price / Book Value ratio x2.64.5 56.5%  
Dividend payout %47.720.5 233.0%   
Avg Mkt Cap Rs m19,508102,081 19.1%   
No. of employees `0000.66.8 8.5%   
Total wages/salary Rs m1,1714,307 27.2%   
Avg. sales/employee Rs Th8,445.43,022.6 279.4%   
Avg. wages/employee Rs Th2,015.7633.4 318.2%   
Avg. net profit/employee Rs Th891.0569.1 156.6%   
INCOME DATA
Net Sales Rs m4,90720,554 23.9%  
Other income Rs m783211 371.3%   
Total revenues Rs m5,68920,765 27.4%   
Gross profit Rs m1235,664 2.2%  
Depreciation Rs m32721 4.4%   
Interest Rs m1612 137.1%   
Profit before tax Rs m8585,143 16.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3401,273 26.7%   
Profit after tax Rs m5183,870 13.4%  
Gross profit margin %2.527.6 9.1%  
Effective tax rate %39.624.8 160.1%   
Net profit margin %10.618.8 56.0%  
BALANCE SHEET DATA
Current assets Rs m8,05511,812 68.2%   
Current liabilities Rs m1,8503,776 49.0%   
Net working cap to sales %126.439.1 323.4%  
Current ratio x4.43.1 139.2%  
Inventory Days Days4577 58.2%  
Debtors Days Days3482 41.6%  
Net fixed assets Rs m15014,398 1.0%   
Share capital Rs m123175 70.4%   
"Free" reserves Rs m7,46922,277 33.5%   
Net worth Rs m7,59222,452 33.8%   
Long term debt Rs m07 0.0%   
Total assets Rs m9,82426,962 36.4%  
Interest coverage x54.9444.3 12.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.8 65.5%   
Return on assets %5.414.4 37.7%  
Return on equity %6.817.2 39.6%  
Return on capital %11.523.0 50.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5810,682 0.5%   
Fx outflow Rs m1,3262,102 63.1%   
Net fx Rs m-1,2698,580 -14.8%   
CASH FLOW
From Operations Rs m-1,9433,748 -51.8%  
From Investments Rs m2,742-2,228 -123.1%  
From Financial Activity Rs m-298-1,475 20.2%  
Net Cashflow Rs m50145 1,109.1%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 1.6 129.0%  
FIIs % 1.6 7.6 21.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 17.0 126.5%  
Shareholders   41,647 20,968 198.6%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; IT and Metal Stocks Under Pressure(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.1% while the Hang Seng is down 0.4%.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

Get Rich as the
Market Rebounds from Covid-19

Coronavirus Rebound
Get this special guide, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 29, 2020 12:21 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - JUBILANT LIFE SCIENCES COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS